CD8A and neoplasm: Martinez-Usatorre et al. then elucidated the mechanism responsible for the increased expression of miR-155 in tumor-infiltrating CD8+ T cells and demonstrated that high miR-155 expression in tumor-infiltrating CD8+ T cells may be a surrogate marker of the relative potency of in situ antigen-specific CD8+ T-cell response (126).